Healthcare provider profile · identity verified

Mary E Broughton, PA-C

Physician Assistant · CRYSTAL, MN · NPI 1487844734

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	411	123
Metoprolol Succinate	Metoprolol Succinate	351	114
Levothyroxine Sodium	Levothyroxine Sodium	317	92
Atorvastatin Calcium	Atorvastatin Calcium	316	94
Rosuvastatin Calcium	Rosuvastatin Calcium	316	97
Lisinopril	Lisinopril	283	88
Losartan Potassium	Losartan Potassium	270	76
Omeprazole	Omeprazole	222	71
Trazodone Hcl	Trazodone Hcl	206	65
Tramadol Hcl	Tramadol Hcl	199	57
Prednisone	Prednisone	198	94
Gabapentin	Gabapentin	195	62
Sertraline Hcl	Sertraline Hcl	194	74
Furosemide	Furosemide	177	65
Oxycodone Hcl	Oxycodone Hcl	142	20
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	122	37
Hydrochlorothiazide	Hydrochlorothiazide	119	35
Lorazepam	Lorazepam	114	24
Eliquis	Apixaban	109	36
Metformin Hcl Er	Metformin Hcl	105	34
Alendronate Sodium	Alendronate Sodium	97	30
Bupropion Xl	Bupropion Hcl	96	26
Warfarin Sodium	Warfarin Sodium	96	26
Tizanidine Hcl	Tizanidine Hcl	91	29
Metformin Hcl	Metformin Hcl	90	26
Pantoprazole Sodium	Pantoprazole Sodium	87	28
Pregabalin	Pregabalin	87	19
Famotidine	Famotidine	81	34
Escitalopram Oxalate	Escitalopram Oxalate	78	18
Azithromycin	Azithromycin	75	53
Fluticasone Propionate	Fluticasone Propionate	75	40
Alprazolam	Alprazolam	69	21
Ozempic	Semaglutide	69	15
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	68	19
Duloxetine Hcl	Duloxetine Hcl	67	25
Simvastatin	Simvastatin	67	20
Albuterol Sulfate Hfa	Albuterol Sulfate	66	40
Citalopram Hbr	Citalopram Hydrobromide	66	19
Cephalexin	Cephalexin	65	50
Atenolol	Atenolol	60	16
Potassium Chloride	Potassium Chloride	57	21
Nystatin	Nystatin	56	35
Triamcinolone Acetonide	Triamcinolone Acetonide	53	39
Spironolactone	Spironolactone	50	14
Zolpidem Tartrate	Zolpidem Tartrate	50	15
Methocarbamol	Methocarbamol	49	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	48	17
Clopidogrel	Clopidogrel Bisulfate	46	16
Meloxicam	Meloxicam	46	12
Tamsulosin Hcl	Tamsulosin Hcl	45	16
Allopurinol	Allopurinol	44	17
Xarelto	Rivaroxaban	43	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	42	32
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	42	13
Venlafaxine Hcl Er	Venlafaxine Hcl	41	suppressed
Buspirone Hcl	Buspirone Hcl	39	13
Fluoxetine Hcl	Fluoxetine Hcl	38	11
Ipratropium Bromide	Ipratropium Bromide	38	14
Metoprolol Tartrate	Metoprolol Tartrate	38	17
Pravastatin Sodium	Pravastatin Sodium	38	12
Hydroxyzine Hcl	Hydroxyzine Hcl	37	12
Ondansetron Odt	Ondansetron	36	17
Doxycycline Hyclate	Doxycycline Hyclate	35	31
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	34	suppressed
Raloxifene Hcl	Raloxifene Hcl	33	suppressed
Amoxicillin	Amoxicillin	32	29
Glimepiride	Glimepiride	32	suppressed
Januvia	Sitagliptin Phosphate	32	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	32	25
Carvedilol	Carvedilol	30	suppressed
Cefuroxime	Cefuroxime Axetil	30	28
Isosorbide Mononitrate Er	Isosorbide Mononitrate	30	11
Lovastatin	Lovastatin	30	suppressed
Glipizide	Glipizide	29	suppressed
Ventolin Hfa	Albuterol Sulfate	29	11
Mirtazapine	Mirtazapine	28	11
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	27	suppressed
Jardiance	Empagliflozin	26	suppressed
Ondansetron Hcl	Ondansetron Hcl	26	suppressed
Synthroid	Levothyroxine Sodium	26	suppressed
Temazepam	Temazepam	26	suppressed
Valacyclovir	Valacyclovir Hcl	26	13
Clonazepam	Clonazepam	25	suppressed
Montelukast Sodium	Montelukast Sodium	25	11
Estradiol	Estradiol	24	11
Fluconazole	Fluconazole	24	19
Ibandronate Sodium	Ibandronate Sodium	24	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	23	11
Valsartan	Valsartan	23	suppressed
Chlorthalidone	Chlorthalidone	22	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	22	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	22	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Memantine Hcl	Memantine Hcl	21	suppressed
Memantine Hcl Er	Memantine Hcl	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	20	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	19	suppressed
Celecoxib	Celecoxib	19	12
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	17
Acetaminophen-Codeine	Acetaminophen With Codeine	18	suppressed
Topiramate	Topiramate	18	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Risperidone	Risperidone	17	suppressed
Naltrexone Hcl	Naltrexone Hcl	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Morphine Sulfate Er	Morphine Sulfate	15	suppressed
Zaleplon	Zaleplon	15	suppressed
Cholestyramine	Cholestyramine (With Sugar)	14	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Linzess	Linaclotide	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Klor-Con M10	Potassium Chloride	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Latanoprost	Latanoprost	12	suppressed
Mupirocin	Mupirocin	12	12
Nitroglycerin	Nitroglycerin	12	suppressed
Torsemide	Torsemide	12	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	12	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Invokana	Canagliflozin	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	11	suppressed
Terconazole	Terconazole	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error